Specialists from the Pasteur Institute of Epidemiology and Microbiology in St. Petersburg have developed a new set of reagents for the detection of antibodies to the coronavirus. The test is registered in Russia, it allows you to determine immunity, including asymptomatic patients. This was reported on the Rospotrebnadzor website.
«St. Petersburg Institute of Epidemiology and Microbiology of Pasteur Rospotrebnadzora has registered a new medical product «Reagent kit for enzyme immuno-quantification of human IgG antibodies against SARS-CoV-2 N protein (N-CoV-2-IgG PS)», the announcement reads.
Unlike other similar kits, it allows to assess not only the presence, but also the concentration of specific antibodies in people infected with the coronavirus who have developed symptoms of the disease, as well as in those who have been sick or have had contact with the virus in the past in the absence of clinical symptoms, he explained. department.
Obtaining information on the concentration of antibodies in humans is important to understand the degree of protection against reinfection reported in Rospotrebnadzor.
Clinical and laboratory tests have confirmed the effectiveness of the test system, it is authorized in Russia, specified in the material.
.
